Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.
Clinical trial NCT04224402 · COMPLETED
Trial details
- NCT number
- NCT04224402
- Sponsor
- Yuhong Li
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2022-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.